Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1

Abstract

The ubiquitin/proteasome pathway has been implicated in a wide variety of cellular processes and the number of substrates degraded by the proteasome is impressive. Most prominently, the stability of a large number of transcription factors is regulated by ubiquitination. To elucidate pathways regulated by the proteasome, gene expression profiles were generated, comparing changes of mRNA expression of 7900 genes from the UniGene collection upon exposure of cells to the proteasome inhibitors Lactacystin, Lactacystin-β-lactone or MG132 by means of microarray based cDNA hybridization. The three profiles were very similar, but differed significantly from a gene expression profile generated with the histone deacetylase inhibitor Trapoxin A, indicating that the observed alterations were indeed due to proteasome inhibition. Two of the most prominently induced genes encoded the growth arrest and DNA damage inducible protein Gadd153 and the activating transcription factor ATF3, both transcription factors of the CCAAT/enhancer binding protein (C/EBP) family. A third gene encoded for the transcriptional repressor and c-Myc antagonist Mad1. Our results suggest that proteasome inhibition leads to upregulation of specific members of transcription factor families controlling cellular stress response and proliferation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S and Elliott PJ . 1999 Cancer Res 59: 2615–2622

  • Amundson SA, Zhan Q, Penn LZ and Fornace Jr AJ . 1998 Oncogene 17: 2149–2154

  • Amundson SA, Bittner M, Chen Y, Trent J, Meltzer P and Fornace Jr AJ . 1999 Oncogene 18: 3666–3672

  • Ayer DE, Kretzner L and Eisenman RN . 1993 Cell 72: 211–222

  • Bai JP . 1995 J Pharm Pharmacol 47: 674–677

  • Blagosklonny MV, Wu GS, Omura A and el Deiry WS . 1996 Biochem Biophys Res Commun 227: 564–569

  • Bogyo M, Gaczynska M and Ploegh HL . 1997 Biopolymers 43: 269–280

  • Bonvini P, Nguyen P, Trepel J and Neckers LM . 1998 Oncogene 16: 1131–1139

  • Bush KT, Goldberg AL and Nigam SK . 1997 J Biol Chem 272: 9086–9092

  • Cailleau R, Young R, Olive M and Reeves Jr WJ . 1974 J Natl Cancer Inst 53: 661–674

  • Chang DD, Park N-H, Denny CT, Nelson SF and Pe M . 1998 Oncogene 16: 1921–1930

  • Chen BP, Wolfgang CD and Hai T . 1996a Mol Cell Biol 16: 1157–1168

  • Chen C, Nussenzweig A, Guo M, Kim D, Li GC and Ling CC . 1996b Oncogene 17: 1659–1665

  • Drexler HCA . 1998 Apoptosis 3: 1–7

  • Eymin B, Dubrez L, Allouche M and Solary E . 1997 Cancer Res 57: 686–695

  • Fawcett TW, Eastman HB, Martindale JL and Holbrook NJ . 1996 J Biol Chem 271: 14285–14289

  • Fawcett TW, Martindale JL, Guyton KZ, Hai T and Holbrook NJ . 1999 Biochem J 339: 135–141

  • Firestein R and Feuerstein N . 1998 J Biol Chem 273: 5892–5902

  • Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H and Parks WP . 1973 J Natl Cancer Inst 51: 1417–1423

  • Goodbourn S and King P . 1997 Biochem Soc Transac 25: 498–502

  • Han S, Park K, Kim HY, Lee MS, Kim HJ and Kim YD . 1999 Oncol Rep 6: 569–574

  • Heid CA, Stevens J, Livak KJ and Williams PM . 1996 Genomic Res 6: 986–994

  • Herrmann JL, Briones Jr F, Brisbay S, Logothetis CJ and McDonnell TJ . 1998 Oncogene 17: 2889–2899

  • Hofmann F, Martelli F, Livingston DM and Wang Z . 1996 Genes Dev 10: 2949–2959

  • Imajoh-Ohmi S, Kawaguchi T, Sugiyama S, Tanaka K, Omura S and Kikuchi H . 1995 Biochem Biophys Res Commun 217: 1070–1077

  • Ichihara A and Tanaka K . 1995 Mol Biol Rep 21: 49–52

  • Kawazoe Y, Nakai A, Tanabe M and Nagata K . 1998 Eur J Biochem 255: 356–362

  • Kitagawa H, Tani E, Ikemoto H, Ozaki I, Nakano A and Omura S . 1999 FEBS Lett 443: 181–186

  • Lee DH and Goldberg AL . 1998 Trends Cell Biol 8: 397–403

  • Liang G, Wolfgang CD, Chen BP, Chen TH and Hai T . 1996 J Biol Chem 271: 1695–1701

  • Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC and Scheithauer BW . 1999 Am J Pathol 154: 313–323

  • Machiels BM, Henfling ME, Gerards WL, Broers JL, Bloemendal H, Ramaekers FC and Schutte B . 1997 Cytometry 28: 243–252

  • Masumoto M, Minami M, Takeda K, Sakao Y and Akira S . 1996 FEBS Lett 395: 143–147

  • Miller G, Fuchs R and Lai E . 1997 Genome Res 7: 1027–1032

  • Outinen PA, Sood SK, Liaw PC, Sarge KD, Maeda N, Hirsh J, Ribeau J, Podor TJ, Weitz JI and Austin RC . 1998 Biochem J 332: 213–221

  • Palombella VJ, Rando OJ, Goldberg AL and Maniatis T . 1994 Cell 78: 773–785

  • Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara Jr RM, Leary AC, Sibley B, Clark SC, Williams DA and Yang YC . 1990 Proc Natl Acad Sci USA 87: 7512–7516

  • Roussel MF, Ashmun RA, Sherr CJ, Eisenman RN and Ayer DE . 1996 Mol Cell Biol 16: 2796–2801

  • Schauber C, Chen L, Tongaonkar P, Vega I, Lambertson D, Potts W and Madura K . 1998 Nature 391: 715–718

  • Schena M, Shalon D, Davis RW and Brown PO . 1995 Science 270: 467–470

  • Schena M, Shalon D, Heller R, Chai A, Brown PO and Davis RW . 1996 Proc Natl Acad Sci USA 93: 10614–10619

  • Shalon D, Smith SJ and Brown PO . 1996 Genome Res 6: 639–645

  • Talley AK, Dewhurst S, Perry SW, Dollard SC, Gummuluru S, Fine SM, New D, Epstein LG, Gendelman HE and Gelbard HA . 1995 Mol Cell Biol 15: 2359–2366

  • Tchernitsa OI, Zuber J, Sers C, Brinckmann R, Britsch SK, Adams V and Schäfer R . 1999 Oncogene 18: 5448–5454

  • User bulletin #2, ABI PRISM 7700 Sequence Detection System 1997 PE Applied Biosystems

  • Van Lint C, Emiliani S and Verdin E . 1996 Gene Expr 5: 245–253

  • Wang X, Luo H, Chen H, Duguid W and Wu J . 1998a J Immunol 160: 788–801

  • Wang XZ, Kuroda M, Sok J, Batchvarova N, Kimmel R, Chung P, Zinszner H and Ron D . 1998b EMBO J 17: 3619–3630

  • Wang XZ, Lawson B, Brewer JW, Zinszner H, Sanjay A, Mi LJ, Boorstein R, Kreibich G, Hendershot LM and Ron D . 1996 Mol Cell Biol 16: 4273–4280

  • Wolfgang CD, Chen BP, Martindale JL, Holbrook NJ and Hai T . 1997 Mol Cell Biol 17: 6700–6707

  • Yoshida H and Sugita K . 1992 Jpn J Cancer Res 83: 324–328

  • Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL and Ron D . 1998 Genes Dev 12: 982–985

Download references

Acknowledgements

We are grateful to the staff at Incyte Inc. (Palo Alto, CA, USA) for performing the array based hybridizations. We thank Lidia Sambucetti for Trapoxin A and Johannes Roesel for his constructive comments on the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zimmermann, J., Erdmann, D., Lalande, I. et al. Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1. Oncogene 19, 2913–2920 (2000). https://doi.org/10.1038/sj.onc.1203606

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203606

Keywords

This article is cited by

Search

Quick links